A potential new vaccine for COVID-19.  The European Commission approved the contract with Valneva

The agreement approved today allows for the vaccine to be adapted to new variants. Our wide range of vaccines will help us In the fight against Covid disease and its variants in Europe and abroad. The epidemic is not over yet. Anyone can get vaccinated – commented the President of the European Commission Ursula von der Leyen.

So far, the European Commission has concluded contracts with companies to produce vaccines in Europe AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna i Novavax.

Valniva is a French biotechnology company that is developing an inactivated virus vaccine, which is produced from live virus by chemical inhibition.

“It is a traditional vaccination technology that has been used for 60-70 years, with established methodology and a high level of safety. Most influenza vaccines and many primary vaccines use this technology. It is currently the only potential inactivated vaccine in clinical trials against Covid-19 in Europe”- The European Commission announced in a press release.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The universe may collapse inward

Since the beginning of our existence, humanity has wondered what the end…

Snakes can swallow almost anything. Scientists know how this is possible

Integrative Organism Biology has published an article explaining why Burmese pythons, considered…

The James Webb Space Telescope was surprised. “Supernova detection machine”

Our partner’s advertising links are included in the text During the 244th…

Scientists use lasers to break nature’s strongest chemical bonds

Some chemical bonds can be really permanent. A way has been found…